Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia.
about
Plasma levels of dimethylarginines in preterm very low birth weight neonates: its relation with perinatal factors and short-term outcome.Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis.Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patientsPolymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in nulliparous women complicated with preeclampsia.Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease.The placental vascular endothelial growth factor polymorphisms and preeclampsia/preeclampsia severity.Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in the placenta of pregnancies complicated with preeclampsia.Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies.Methemoglobin levels in umbilical cord blood of women with intrauterine growth restriction and preeclampsia.Associations between vascular endothelial growth factor gene polymorphisms and pre-eclampsia susceptibility: a meta-analysis.The association of the placental MTHFR 3'-UTR polymorphisms, promoter methylation, and MTHFR expression with preeclampsia.Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level.Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile.
P2860
Q35016382-1F847E77-7805-4EA2-B9B6-96F8437190CBQ35040818-8DAE6D6F-4D8E-41FA-89CB-1BE38B8F048AQ37206251-F2D43A65-596C-4559-BFF2-F690E3CEB082Q39235492-606D0ED3-C2C2-4BB0-B313-AE10994725BEQ39852913-2DF4B68B-519C-4E8A-9B84-2638235CF6B9Q40139697-4E520F56-CE6C-4C65-97C8-60B1EA60E124Q40876699-70B817B9-2FCA-487A-905E-A4A655106FAAQ42439680-C1C00BAE-4180-464E-B919-400AB44312BFQ44824431-87D9BEDC-33C2-4C42-A9CB-412B6E7225FBQ47749472-1F6A55E3-C242-45DC-BE83-F4F263D10688Q48102220-9FEEA257-9C9F-44C3-8AC9-A9A6C85889F2Q48117226-B59409E4-0768-49B8-8C89-B4963D701646Q55073231-9B24943D-D0C5-40F9-AEFD-BF805A413F5D
P2860
Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Feto-placental nitric oxide, a ...... phisms in severe preeclampsia.
@en
Feto-placental nitric oxide, a ...... phisms in severe preeclampsia.
@nl
type
label
Feto-placental nitric oxide, a ...... phisms in severe preeclampsia.
@en
Feto-placental nitric oxide, a ...... phisms in severe preeclampsia.
@nl
prefLabel
Feto-placental nitric oxide, a ...... phisms in severe preeclampsia.
@en
Feto-placental nitric oxide, a ...... phisms in severe preeclampsia.
@nl
P2093
P2860
P50
P1476
Feto-placental nitric oxide, a ...... phisms in severe preeclampsia.
@en
P2093
Andrea R Genazzani
Eleonora Russo
Emilio J Solis
Guido Bocci
Gustavo S Escobar
Luis Hidalgo
Paolo Mannella
Santhosh Gopal
P2860
P304
P356
10.3109/14767058.2012.733760
P577
2012-10-18T00:00:00Z